ArticleFrontiers in public health2024
Estimates of the excess cost burden of Ehlers-Danlos syndromes: a United States MarketScan® claims database analysis.
Jane R Schubart et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papertrialcites it